TY - JOUR
T1 - Critical pre-examination variables in the hemostasis laboratory and their quality indicators
AU - Adcock, Dorothy M
AU - Favaloro, Emmanuel J
AU - Lippi, Giuseppe
N1 - Copyright © 2016. Published by Elsevier Inc.
PY - 2016/12
Y1 - 2016/12
N2 - The total testing process comprises a number of phases of laboratory testing, which can be broadly considered as comprising pre-examination, examination and post-examination activities. Although each phase is crucial to providing accurate and meaningful laboratory results, the pre-examination phase of testing is where most laboratory errors currently occur, and thus requires special attention. The activities in this phase include sample collection, handling, transportation, processing and storage, which are frequently outside the control of the laboratory performing the tests. Samples for hemostasis testing are particularly vulnerable to pre-analytical variables, which may ultimately lead to inappropriate test results. We outline here several strategies to mitigate potential problems in the pre-examination phase. We also recommend the implementation of several processes to reduce errors.
AB - The total testing process comprises a number of phases of laboratory testing, which can be broadly considered as comprising pre-examination, examination and post-examination activities. Although each phase is crucial to providing accurate and meaningful laboratory results, the pre-examination phase of testing is where most laboratory errors currently occur, and thus requires special attention. The activities in this phase include sample collection, handling, transportation, processing and storage, which are frequently outside the control of the laboratory performing the tests. Samples for hemostasis testing are particularly vulnerable to pre-analytical variables, which may ultimately lead to inappropriate test results. We outline here several strategies to mitigate potential problems in the pre-examination phase. We also recommend the implementation of several processes to reduce errors.
KW - Anticoagulants/blood
KW - Hemostasis
KW - Humans
KW - Quality Indicators, Health Care
U2 - 10.1016/j.clinbiochem.2016.08.022
DO - 10.1016/j.clinbiochem.2016.08.022
M3 - Article
C2 - 27614216
SN - 1873-2933
VL - 49
SP - 1315
EP - 1320
JO - Clinical Biochemistry
JF - Clinical Biochemistry
IS - 18
ER -